Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 25,000 shares at $40.00 ($1.0M) on 2020-01-29, disclosed to the SEC on 2020-01-31.
Seasonal sale ($1.0M) by President, CEO, & Director — this insider has traded ATRC in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |